8-KCOAGCIK 0002114044
Hemab Therapeutics Holdings, Inc.
Material event (8-K) filed .
Current report announcing a material event, such as an acquisition, executive change, or earnings release.
New to the 8-K? What it is and how to read oneFiling facts
- Accession number
- 0001193125-26-216699
- Filer
- Hemab Therapeutics Holdings, Inc.
- Ticker
- COAG
- CIK
- 0002114044
- Form type
- 8-K
- Form description
- Material event
- Filed at
- May 11, 2026
- Period of report
- May 8, 2026
- Industry
- SIC 2836Biological Products
- Filing size
- 137.8 KB
- Last verified
- August 26, 2026SecFilingDex pulls from EDGAR with daily cadence
More filings from Hemab Therapeutics Holdings, Inc.
See all 27 filings from Hemab Therapeutics Holdings, Inc. →Provenance
Authoritative source — SEC EDGAR
https://www.sec.gov/Archives/edgar/data/2114044/000119312526216699/0001193125-26-216699-index.htm ↗Filer's full EDGAR submission history
EDGAR · Hemab Therapeutics Holdings, Inc. (0002114044) ↗SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.